We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Medicenna Therapeutics Corp (MDNA) NPV

Sell:2.42 CAD Buy:2.54 CAD Change: 0.14 CAD (5.45%)
Market closed |  Prices as at close on 26 November 2021 | Switch to live prices |
Sell:2.42 CAD
Buy:2.54 CAD
Change: 0.14 CAD (5.45%)
Market closed |  Prices as at close on 26 November 2021 | Switch to live prices |
Sell:2.42 CAD
Buy:2.54 CAD
Change: 0.14 CAD (5.45%)
Market closed |  Prices as at close on 26 November 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Medicenna Therapeutics Corp. is an immunotherapy company. The Company is engaged in the development and commercialization of interleukin-2 (IL-2), interleukin-4 (IL-4) and interleukin-13 (IL-13) tunable cytokines, called Superkines and Empowered Superkines (ECs). It focuses on commercialization of EC and Superkines for the treatment of cancer and other diseases. The Company’s Bi-functional SuperKine ImmunoTherapies (BiSKITs) platform allows to develop designer Superkines by combining them to other proteins, antibodies or naked IL-2, IL-4 and IL-13 Superkines to combine two distinct and synergistic mechanisms of action into one molecule. The Company’s product candidates MDNA55, is an Empowered Superkine developed as a therapeutic for recurrent glioblastoma multiforme (rGBM), a fatal form of brain cancer. MDNA11, an IL-2 Superkine that has been fused with human recombinant albumin. It is being developed as a therapeutic for various solid tumors in combination with other immunotherapies.

Contact details

Address:
2 Bloor St W 7th Floor
TORONTO
M4W 3E2
Canada
Telephone:
+1 (416) 6485555
Website:
https://www.medicenna.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
MDNA
ISIN:
CA58490H1073
Market cap:
138.19 million CAD
Shares in issue:
53.98 million
Sector:
Biotechnology
Exchange:
Toronto Stock Exchange
Country:
Canada
Currency:
Canadian dollars
Indices:
n/a

Key personnel

  • Fahar Merchant
    Chairman of the Board, President, Chief Executive Officer
  • Elizabeth Williams
    Chief Financial Officer, Corporate Secretary
  • Rosemina Merchant
    Director, Chief Development Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.